These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19773667)

  • 21. Uptake of interferon-free DAA therapy among HCV-infected decompensated cirrhosis patients and evidence for decreased mortality.
    McDonald SA; Barclay ST; Innes HA; Fraser A; Hayes PC; Bathgate A; Dillon JF; Went A; Goldberg DJ; Hutchinson SJ
    J Viral Hepat; 2021 Sep; 28(9):1246-1255. PubMed ID: 34002914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030.
    Meijerink H; White RA; Løvlie A; de Blasio BF; Dalgard O; Amundsen EJ; Melum E; Kløvstad H
    BMC Infect Dis; 2017 Aug; 17(1):541. PubMed ID: 28774261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
    Carrat F; Fontaine H; Dorival C; Simony M; Diallo A; Hezode C; De Ledinghen V; Larrey D; Haour G; Bronowicki JP; Zoulim F; Asselah T; Marcellin P; Thabut D; Leroy V; Tran A; Habersetzer F; Samuel D; Guyader D; Chazouilleres O; Mathurin P; Metivier S; Alric L; Riachi G; Gournay J; Abergel A; Cales P; Ganne N; Loustaud-Ratti V; D'Alteroche L; Causse X; Geist C; Minello A; Rosa I; Gelu-Simeon M; Portal I; Raffi F; Bourliere M; Pol S;
    Lancet; 2019 Apr; 393(10179):1453-1464. PubMed ID: 30765123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study.
    Wong WWL; Haines A; Bremner KE; Yao Z; Calzavara A; Mitsakakis N; Kwong JC; Sander B; Thein HH; Krahn MD
    CMAJ Open; 2021; 9(1):E167-E174. PubMed ID: 33688024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.
    García-García JA; Romero-Gómez M; Girón-González JA; Rivera-Irigoin R; Torre-Cisneros J; Montero JL; González-Serrano M; Andrade RJ; Aguilar-Guisado M; Grilo I; Martín-Vivaldi J; Salmerón J; Caballero-Granado FJ; Macías J; Vergara-López S; Pineda JA; ;
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1236-41. PubMed ID: 17209765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.
    Thein HH; Yi Q; Dore GJ; Krahn MD
    AIDS; 2008 Oct; 22(15):1979-91. PubMed ID: 18784461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
    Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
    Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland.
    Prevost TC; Presanis AM; Taylor A; Goldberg DJ; Hutchinson SJ; De Angelis D
    Addiction; 2015 Aug; 110(8):1287-300. PubMed ID: 25876667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.
    Pineda JA; Romero-Gómez M; Díaz-García F; Girón-González JA; Montero JL; Torre-Cisneros J; Andrade RJ; González-Serrano M; Aguilar J; Aguilar-Guisado M; Navarro JM; Salmerón J; Caballero-Granado FJ; García-García JA; ;
    Hepatology; 2005 Apr; 41(4):779-89. PubMed ID: 15800956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
    Gebo KA; Diener-West M; Moore RD
    J Acquir Immune Defic Syndr; 2003 Oct; 34(2):165-73. PubMed ID: 14526205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
    Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
    J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
    Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
    J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
    Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.
    Soriano V; García-Samaniego J; Valencia E; Rodríguez-Rosado R; Muñoz F; González-Lahoz J
    Eur J Epidemiol; 1999 Jan; 15(1):1-4. PubMed ID: 10098988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
    Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M
    PLoS One; 2016; 11(5):e0153744. PubMed ID: 27148964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in hepatitis C-related liver disease in a large clinic population.
    Ostapowicz G; Dallinger M; Bell SJ; Strasser SI; Watson KJ; Slavin J; Santamaria J; Desmond PV
    Intern Med J; 2001 Mar; 31(2):90-6. PubMed ID: 11480484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland.
    Hutchinson SJ; Bird SM; Goldberg DJ
    Hepatology; 2005 Sep; 42(3):711-23. PubMed ID: 16116637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
    Murcia J; Portilla J; Bedia M; Palazón JM; Sánchez-Payá J; Saiz de la Hoya P; Payá A; Boix V; Merino E; Reus S
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):206-12. PubMed ID: 19246126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.